Last reviewed · How we verify
Adenosine deaminase deficiency
Approved treatments
- Revcovi · Leadiant Biosci Inc
Revcovi works by replacing the deficient enzyme adenosine deaminase, allowing the body to break down toxic substances. - Adagen · Leadiant Biosciences, Inc.
- pegademase
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Adenosine deaminase deficiency patent landscape — cliff calendar, originator estates, attackable patents
- Adenosine deaminase deficiency treatment landscape brief
- Adenosine deaminase deficiency treatment updates RSS
Frequently asked questions about Adenosine deaminase deficiency
What drugs treat Adenosine deaminase deficiency?
Tracked treatments include Revcovi, Adagen, pegademase.
What is the treatment for Adenosine deaminase deficiency?
Standard treatment for Adenosine deaminase deficiency includes Revcovi, Adagen, pegademase. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Adenosine deaminase deficiency patent cliff · Adenosine deaminase deficiency CI report
- Treatment: Revcovi · Leadiant Biosci Inc
- Treatment: Adagen · Leadiant Biosciences, Inc.
- Treatment: pegademase
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing